4.2 Article

Comparative study on ABCB1-dependent efflux of anthracyclines and their metabolites: consequences for cancer resistance

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Structure-Function Relationships in the Human P-Glycoprotein (ABCB1): Insights from Molecular Dynamics Simulations

Liadys Mora Lagares et al.

Summary: P-gp is an important protein involved in drug efflux and multidrug resistance. Molecular dynamics simulations can provide valuable insights into the binding behavior and conformational changes of P-gp in the presence of different compounds.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Biochemistry & Molecular Biology

Recent Advances on P-Glycoprotein (ABCB1) Transporter Modelling with In Silico Methods

Liadys Mora Lagares et al.

Summary: ABC transporters, especially P-glycoprotein (P-gp), play a critical role in drug bioavailability and toxicity. Efforts to reverse multidrug resistance (MDR) associated with overexpression of P-gp have been extensive but have yet to yield effective inhibitors due to their toxic effects. Computational studies and in silico models have shown promise in accelerating the development of P-gp inhibitors and understanding drug-transporter interactions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Pharmacology & Pharmacy

Implication of ABC transporters in non-proliferative diseases

Tatyana A. Grigoreva et al.

Summary: ABC transporters play a crucial role in multidrug resistance and maintaining overall viability. Modulating the activity of these transporters holds promise in overcoming drug delivery challenges and treating diseases caused by genetic polymorphisms.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Review Multidisciplinary Sciences

P-glycoprotein and cancer: what do we currently know?

Carlos Pilotto Heming et al.

Summary: Acquired resistance during cancer treatment is often caused by ABC transporters, such as P-gp, which export chemotherapeutic molecules and contribute to multidrug resistance. In addition to its role in drug resistance, P-gp may also have other functions and serve as a biomarker in cancer.

HELIYON (2022)

Review Cell Biology

Metabolic and non-metabolic pathways that control cancer resistance to anthracyclines

Tania Capeloa et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)

Review Oncology

Resistance to anti-tubulin agents: From vinca alkaloids to epothilones

Werner Krause

CANCER DRUG RESISTANCE (2019)

Review Oncology

Revisiting the role of ABC transporters in multidrug-resistant cancer

Robert W. Robey et al.

NATURE REVIEWS CANCER (2018)

Article Chemistry, Medicinal

Molecular Docking Characterizes Substrate-Binding Sites and Efflux Modulation Mechanisms within P-Glycoprotein.

Ricardo J. Ferreira et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)

Article Biochemistry & Molecular Biology

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

G. Madhavi Sastry et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)

Article Chemistry, Medicinal

Identifying and Characterizing Binding Sites and Assessing Druggability

Thomas A. Halgren

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)

Article Multidisciplinary Sciences

Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

Stephen G. Aller et al.

SCIENCE (2009)

Article Chemistry, Medicinal

Novel procedure for modeling ligand/receptor induced fit effects

W Sherman et al.

JOURNAL OF MEDICINAL CHEMISTRY (2006)